Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal Cancer

CONCLUSIONS: Our results suggest that P85-Ab is a promising novel biomarker for nasopharyngeal carcinoma screening, with higher sensitivity, specificity, and positive predictive value than the standard two-antibody method. (Funded by the National Key Research and Development Program of China and others; ClinicalTrials.gov number, NCT04085900.).PMID:37646678 | DOI:10.1056/NEJMoa2301496

Source: Cancer Control - August 30, 2023 Category: Cancer & Oncology Authors: Tingdong Li Fugui Li Xiaoyi Guo Congming Hong Xia Yu Biaohua Wu Shifeng Lian Liuwei Song Jiabao Tang Shunhua Wen Kaimin Gao Mengling Hao Weimin Cheng Yingying Su Shiyin Zhang Shoujie Huang Mujin Fang Yingbin Wang Mun-Hon Ng Honglin Chen Wenxin Luo Shengxi Source Type: research